SAN DIEGO, March 3, 2014 /PRNewswire/ -- Trovagene, Inc. (NASDAQ: TROV), a developer of cell-free molecular diagnostics, announced today that it will report financial results for the quarter and year ended December 31, 2013 on Monday, March 17, 2014 at 4:00 p.m. Eastern Daylight Time (1:00 p.m. Pacific Daylight Time).
Trovagene's management team will host a conference call on Monday, March 17, 2014 at 5:00 p.m. Eastern Daylight Time (2:00 p.m. Pacific Daylight Time) to discuss the results and update investors on the company's progress.
A live webcast of the call will be available online at www.trovagene.investorroom.com. To access the conference call, please dial (877) 870-4263 (domestic), (412) 317-0790 (international), or (855) 669-9657 (Canada), conference ID# 10042191. To access the telephone replay of the call, dial (877) 344-7529 (domestic) or (412) 317-0088 (international), replay ID# 10042191. The webcast and telephone replay will be archived on the company's website following the call.
About Trovagene, Inc.
Headquartered in San Diego, California, Trovagene is leveraging its patented technology for the detection of cell-free DNA and RNA, short nucleic acid fragments originating from normal and diseased cell death that can be isolated and detected from urine. Trovagene has a strong intellectual property asset as it relates to cell-free DNA and RNA testing in urine. It has U.S. and European patent applications and issued patents that cover testing for HPV and other infectious diseases, cancer, transplantation, prenatal and genetic testing.
SOURCE Trovagene, Inc.